[
  {
    "ts": "2025-10-08T23:17:01+00:00",
    "headline": "Gilead Sciences Rallies After Trump Partnership News Is the Growth Story Just Beginning",
    "summary": "Thinking about what to do with Gilead Sciences stock right now? You are not alone. With shares closing at $118.25 and up an impressive 41.4% over the past year, many investors are weighing whether to ride the momentum or lock in gains. The real story lies in both recent catalysts and the company’s more subtle shifts in risk perception. Over the last week, Gilead climbed 6.4%. That is not a small move, and those gains built on a robust year-to-date return of 28.7%. Market watchers are eyeing...",
    "url": "https://finance.yahoo.com/news/gilead-sciences-rallies-trump-partnership-231701414.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6076158e-eae2-3bf6-a089-188fca7333d6",
      "content": {
        "id": "6076158e-eae2-3bf6-a089-188fca7333d6",
        "contentType": "STORY",
        "title": "Gilead Sciences Rallies After Trump Partnership News Is the Growth Story Just Beginning",
        "description": "",
        "summary": "Thinking about what to do with Gilead Sciences stock right now? You are not alone. With shares closing at $118.25 and up an impressive 41.4% over the past year, many investors are weighing whether to ride the momentum or lock in gains. The real story lies in both recent catalysts and the company’s more subtle shifts in risk perception. Over the last week, Gilead climbed 6.4%. That is not a small move, and those gains built on a robust year-to-date return of 28.7%. Market watchers are eyeing...",
        "pubDate": "2025-10-08T23:17:01Z",
        "displayTime": "2025-10-08T23:17:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HAEiJmFsYXJTRBPxnneP6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXB9F2qU7k4qk3_k1DQd9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-rallies-trump-partnership-231701414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-rallies-trump-partnership-231701414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]